Skip to main content
. Author manuscript; available in PMC: 2019 Nov 15.
Published in final edited form as: Int J Cardiol. 2018 Nov 15;271:60–65. doi: 10.1016/j.ijcard.2018.04.089

Table 3.

Comparison of baseline variables between subject with or without a major outcome event.

Variable No Event
N=38
Event
N=14
P
N=38
Age (years) 32.7 ± 9.8 39.4 ± 10.7 0.038
Female 17 (45%) 4 (29%) 0.29
ECV (%) 27.6 ± 3.5 31.8 ± 5.3 0.002
Elevated ECV 7 (18%) 8 (57%) 0.005
Lambda 0.479 ± 0.056 0.543 ± 0.085 0.003
Native T1 (ms) 952 ± 183 984 ± 235 0.61
Post contrast T1 (ms) 425 ± 110 316 ± 67 0.001
Hematocrit (%) 42.3 ± 3.2 41.6 ± 3.1 0.49
Congenitally-corrected TGA 6 (16%) 3 (21%) 0.63
Prior atrial arrhythmia 11 (29%) 6 (43%) 0.34
Beta blocker use 9 (24%) 2 (14%) 0.46
ACEi/ARB use 9 (24%) 6 (43%) 0.18
Aldosterone inhibitor use 1 (3%) 2 (14%) 0.11
Loop diuretic use 8 (21%) 5 (36%) 0.28
QRS duration (ms) 99 ± 40 108 ± 11 0.57
Baseline heart rate (bpm) 69 ± 14 76 ± 16 0.12
Baseline O2 saturation (%) 97 ± 2 96 ± 3 0.29
Systolic blood pressure (mmHg) 122 ± 11 115 ± 10 0.051
6MWT post heart rate (bpm) 105 ± 26 104 ± 22 0.89
6MWT post O2 saturation (%) 96 ± 4 91 ± 5 0.007
6MWT distance (m) 484 ± 120 471 ± 111 0.76
Body surface area (m2) 1.97 ± 0.22 1.96 ± 0.23 0.73
RVEDVi (ml/m2) 99 ± 25 112 ± 31 0.18
RVESVi (ml/m2) 47 ± 20 66 ± 32 0.013
RVEF (%) 54 ± 9 43 ± 11 0.002
Moderate-severe TR 9 (24%) 5 (36%) 0.39
RV mass index (g/m2) 88.1 ± 19.7 91.5 ± 19.6 0.62
LGE present 6 (16%) 1 (7%) 0.43
Sodium (mmol/l) 139 ± 2 137 ± 2 0.002
Creatinine (mg/dl) 0.83 ± 0.16 0.85 ± 0.13 0.53
ln BNP 4.48 ± 1.07 5.23 ± 1.34 0.047

Values are given as N (%), mean±SD, or median [interquartile range]. TGA = transposition of the great arteries. ECV = extracellular volume fraction. Lambda is the partition coefficient of gadolinium. ACEi= angiotensin converting enzyme inhibitor. ARB = angiotensin receptor blocker. 6MWT = six-minute walk test. RVEDVi = RV end-diastolic volume index, RVESVi = RV end-systolic volume index. BNP = b-type natriuretic peptide.